Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Rangering i aksjer
#4605
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Aksjekurs
$3.28
Markedsverdi
$3.32B
Endring (1 dag)
4.19%
Endring (1 år)
-10.41%
Land
CN
Handel Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Kategori
Healthcare
Inntekter for Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Inntekter i Jun 2026 TTM: $178.32M
Ifølge Jiangsu Nhwa Pharmaceutical Co., Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat $178.32M. I 2023 hadde selskapet et resultat på $165.10M, en økning sammenlignet med resultatet i 2022, som var $143.51M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Jiangsu Nhwa Pharmaceutical Co., Ltd. fra 2005 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $178.32M | 0.37% |
| 2024 | $177.65M | 7.60% |
| 2023 | $165.10M | 15.04% |
| 2022 | $143.51M | -0.40% |
| 2021 | $144.08M | 10.67% |
| 2020 | $130.19M | 18.18% |
| 2019 | $110.16M | 24.59% |
| 2018 | $88.42M | 29.21% |
| 2017 | $68.43M | 32.53% |
| 2016 | $51.63M | 11.41% |
| 2015 | $46.35M | 10.03% |
| 2014 | $42.12M | 24.43% |
| 2013 | $33.85M | 27.40% |
| 2012 | $26.57M | 38.55% |
| 2011 | $19.18M | 40.39% |
| 2010 | $13.66M | 48.52% |
| 2009 | $9.20M | 26.55% |
| 2008 | $7.27M | 35.65% |
| 2007 | $5.36M | 134.21% |
| 2006 | $2.29M | 10.87% |
| 2005 | $2.06M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 889.56% |
IN
|
